Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 2546402, 9 pages
http://dx.doi.org/10.1155/2016/2546402
Research Article

Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9

1Division of Respiratory Medicine, Taizhou Enze Medical Center Enze Hospital, Taizhou, Zhejiang 318000, China
2Division of Equipment, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
3Division of Intensive Care Unit, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo, Zhejiang 315040, China
4Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University and Key Laboratory of Heart and Lung, Wenzhou, Zhejiang 325035, China

Received 29 April 2016; Revised 7 August 2016; Accepted 11 August 2016

Academic Editor: Ki-Wan Oh

Copyright © 2016 Shuangquan Yan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. R. Stenmark, K. A. Fagan, and M. G. Frid, “Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms,” Circulation Research, vol. 99, no. 7, pp. 675–691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-J. Suh, J.-R. Kim, U.-H. Jin et al., “Deoxypodophyllotoxin, flavolignan, from Anthriscus sylvestris Hoffm. inhibits migration and MMP-9 via MAPK pathways in TNF-α-induced HASMC,” Vascular Pharmacology, vol. 51, no. 1, pp. 13–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-J. Suh, U.-H. Jin, S.-H. Kim et al., “Ochnaflavone inhibits TNF-α-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9,” Journal of Cellular Biochemistry, vol. 99, no. 5, pp. 1298–1307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Radziwon-Balicka, M. J. Santos-Martinez, J. J. Corbalan et al., “Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway,” Carcinogenesis, vol. 35, no. 2, pp. 324–332, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Grossi, A. Peserico, T. Tezil, and C. Simone, “p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance,” World Journal of Gastroenterology, vol. 20, no. 29, pp. 9744–9758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Spallarossa, P. Altieri, S. Garibaldi et al., “Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: the role of MAP kinases and NAD(P)H oxidase,” Cardiovascular Research, vol. 69, no. 3, pp. 736–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Gao, K. Huang, and H. Xu, “Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells,” Pharmacological Research, vol. 43, no. 2, pp. 173–178, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lin, L. Li, L. Li et al., “The protective effect of baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis,” BMC Complementary and Alternative Medicine, vol. 14, article 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Guo, N. Zhang, D. Li et al., “Baicalin plays an anti-inflammatory role through reducing nuclear factor-κB and p38 phosphorylation in S. aureus-induced mastitis,” International Immunopharmacology, vol. 16, no. 2, pp. 125–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Liu, S. Yan, M. Chen et al., “Effects of baicalin on collagen I and collagen III expression in pulmonary arteries of rats with hypoxic pulmonary hypertension,” International Journal of Molecular Medicine, vol. 35, no. 4, pp. 901–908, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Jo, S. H. Jung, H. B. Yim, S. J. Lee, and K. D. Kang, “The effect of baicalin in a mouse model of retinopathy of prematurity,” BMB Reports, vol. 48, no. 5, pp. 271–276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-F. Wang, Q.-M. Zhou, J. Du, H. Zhang, Y.-Y. Lu, and S.-B. Su, “Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 6, pp. 923–931, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Tajsic and N. W. Morrell, “Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension,” Comprehensive Physiology, vol. 1, no. 1, pp. 295–317, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. E. Wagenseil and R. P. Mecham, “Vascular extracellular matrix and arterial mechanics,” Physiological Reviews, vol. 89, no. 3, pp. 957–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Chelladurai, W. Seeger, and S. S. Pullamsetti, “Matrix metalloproteinases and their inhibitors in pulmonary hypertension,” European Respiratory Journal, vol. 40, no. 3, pp. 766–782, 2012. View at Publisher · View at Google Scholar
  16. N. Li, D.-Z. Dai, and Y. Dai, “CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 378, no. 5, pp. 541–552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Hedin, B. A. Bottger, E. Forsberg, S. Johansson, and J. Thyberg, “Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells,” Journal of Cell Biology, vol. 107, no. 1, pp. 307–319, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes, “Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9,” Circulation, vol. 96, no. 10, pp. 3555–3560, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Zempo, N. Koyama, R. D. Kenagy, H. J. Lea, and A. W. Clowes, “Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 1, pp. 28–33, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Lepetit, S. Eddahibi, E. Fadel et al., “Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension,” European Respiratory Journal, vol. 25, no. 5, pp. 834–842, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. C. Platanias, “Map kinase signaling pathways and hematologic malignancies,” Blood, vol. 101, no. 12, pp. 4667–4679, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ricote, I. García-Tuñón, F. Bethencourt et al., “The p38 transduction pathway in prostatic neoplasia,” Journal of Pathology, vol. 208, no. 3, pp. 401–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-L. Chen, Y.-X. Wu, Y.-Y. Huang et al., “AVE0991, a nonpeptide compound, attenuates angiotensin II-induced vascular smooth muscle cell proliferation via induction of heme oxygenase-1 and downregulation of p-38 mapk phosphorylation,” International Journal of Hypertension, vol. 2012, Article ID 958298, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Li, Q. Wang, Q. Xu et al., “Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor,” Life Sciences, vol. 110, no. 2, pp. 70–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Cho, J. Graves, and M. A. Reidy, “Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 12, pp. 2527–2532, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Dodd, R. Jadhav, L. Wiggins et al., “MMPs2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK,” Journal of Molecular and Cellular Cardiology, vol. 51, no. 6, pp. 1015–1025, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Cheng, L. Wei, W. Xiurong, L. Xiangzhen, Z. Shiguang, and F. Songbin, “IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-κB and AP-1 activation,” Cellular and Molecular Neurobiology, vol. 29, no. 8, pp. 1161–1168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Morin, R. Hiram, E. Rousseau, P. U. Blier, and S. Fortin, “Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 307, no. 4, pp. H574–H586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Li, M. Mao, Y. Qiu et al., “Key role of ROS in the process of 15-lipoxygenase/15-hydroxyeicosatetraenoiccid-induced pulmonary vascular remodeling in hypoxia pulmonary hypertension,” PLoS ONE, vol. 11, no. 2, article e0149164, 2016. View at Publisher · View at Google Scholar